At3g19810 Antibody

What criteria should researchers use when selecting an At3g19810 antibody for experiments?

When selecting an At3g19810 antibody for Arabidopsis thaliana research, consider four critical factors: (1) antibody origin and clonality (monoclonal vs. polyclonal), (2) documented specificity through proper characterization, (3) validated performance in your intended application (immunoblot, immunofluorescence, etc.), and (4) ability to recognize the specific epitope of interest. For optimal results, prioritize antibodies with published validation data demonstrating binding specifically to At3g19810 protein. Commercial options like CSB-PA440174XA01DOA (targeting Q9LT27) are available for this specific Arabidopsis protein . Remember that approximately 50% of commercial antibodies fail to meet basic characterization standards, potentially leading to irreproducible results and significant research waste .

How can I validate that my At3g19810 antibody is specifically recognizing the target protein?

To validate At3g19810 antibody specificity, implement a comprehensive validation strategy: (1) Perform western blots comparing wild-type Arabidopsis with At3g19810 knockout/knockdown lines to confirm signal reduction/absence in the mutant; (2) Test reactivity against recombinant At3g19810 protein; (3) Include pre-absorption controls using purified antigen; (4) Test cross-reactivity with closely related DUF177 family proteins; and (5) Validate through orthogonal techniques such as mass spectrometry identification of immunoprecipitated proteins. Document that the antibody binds to the target protein in complex protein mixtures and does not cross-react with other proteins under your experimental conditions . Controls using tissues where At3g19810 is known to be highly expressed versus tissues with minimal expression provide additional validation evidence.

What is known about the biological function of the At3g19810 protein in Arabidopsis thaliana?

The At3g19810 gene encodes a protein classified as DUF177A (Domain of Unknown Function 177 A) , suggesting its molecular function remains incompletely characterized. Current research indicates it belongs to a family of proteins containing a conserved domain of unknown function. The protein is expressed in Arabidopsis thaliana (mouse-ear cress) and likely plays a role in plant-specific cellular processes. Unlike well-characterized proteins such as ANAC009 or other NAC domain-containing transcription factors, the precise biological functions, cellular localization, and interacting partners of At3g19810 require further investigation. The availability of specific antibodies like CSB-PA440174XA01DOA enables researchers to study its expression patterns, protein-protein interactions, and potential roles in plant development or stress responses.

What are the optimal sample preparation protocols for detecting At3g19810 protein in different applications?

For optimal At3g19810 protein detection, sample preparation protocols must be tailored to both the application and the tissue type:

For immunoblotting:

• Extract proteins from Arabidopsis tissues using buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, protease inhibitor cocktail

• Homogenize tissues thoroughly (mortar and pestle with liquid nitrogen for complete disruption)

• Centrifuge lysates at 14,000×g for 15 minutes at 4°C and collect supernatant

• Quantify protein concentration using Bradford or BCA assay

• Add Laemmli buffer and heat at 95°C for 5 minutes before loading 20-50 μg protein per lane

For immunohistochemistry:

• Fix tissues in 4% paraformaldehyde for 16-24 hours

• Dehydrate through ethanol series and embed in paraffin

• Section tissues at 5-10 μm thickness

• Perform antigen retrieval (10 mM sodium citrate buffer, pH 6.0, at 95°C for 20 minutes)

• Block with 5% normal goat serum, 1% BSA, 0.2% Triton X-100

• Incubate with primary antibody at 1:25 to 1:250 dilution, depending on antibody concentration

The critical step is optimization of fixation conditions to preserve epitope recognition while maintaining tissue morphology. Testing multiple fixatives and antigen retrieval methods is recommended for novel antibodies lacking established protocols.

How should I design controls for experiments using At3g19810 antibody?

Design a comprehensive control strategy for At3g19810 antibody experiments that includes:

• Genetic controls: Compare wild-type Arabidopsis with At3g19810 knockout/knockdown mutants or overexpression lines to validate signal specificity

• Peptide competition controls: Pre-incubate antibody with excess purified At3g19810 peptide antigen before application to verify signal elimination

• Secondary antibody-only controls: Omit primary antibody to assess non-specific binding of secondary antibody

• Isotype controls: Use non-specific antibodies of the same isotype and concentration to evaluate background

• Tissue-specific controls: Compare tissues with known differential expression of At3g19810

• Recombinant protein controls: For quantitative assays, include purified recombinant At3g19810 protein as standard curve

For immunofluorescence microscopy, include additional controls like fluorophore-only samples to assess autofluorescence, particularly important in plant tissues where chlorophyll can interfere with signal interpretation . When performing ELISA, include both positive controls (known antibody that cross-reacts with At3g19810) and negative controls (supernatants from cells not expressing At3g19810 binding activity) .

How can I optimize immunoprecipitation protocols for studying At3g19810 protein interactions?

Optimizing immunoprecipitation (IP) for At3g19810 protein interactions requires systematic refinement of several parameters:

• Lysis buffer optimization: Test multiple buffers varying in salt concentration (150-500 mM NaCl), detergent type and concentration (0.1-1% NP-40, Triton X-100, or digitonin), and pH (6.8-8.0) to maximize protein extraction while preserving interactions

• Antibody coupling strategy: Compare direct coupling to beads (using commercial coupling kits) versus indirect capture using Protein A/G beads, evaluating which approach yields cleaner results with less background

• IP conditions optimization: Test varying antibody concentrations (1-10 μg per reaction), incubation times (2 hours to overnight), and temperatures (4°C vs. room temperature)

• Washing stringency balance: Develop a washing protocol that removes non-specific binders while preserving genuine interactions (typically 3-5 washes with decreasing detergent concentrations)

• Elution method selection: Compare various elution methods (low pH, competitive peptide elution, or direct boiling in SDS sample buffer) for efficiency

For identifying novel protein interactors, couple optimized IP with mass spectrometry analysis and validate findings using reciprocal co-IP or proximity labeling approaches. When analyzing plant proteins like At3g19810, include additional steps to remove abundant photosynthetic proteins and plant-specific compounds that can interfere with IP efficiency. Record detailed protocols to enable reproducibility across experiments and research groups.

What approaches can resolve contradictory data when At3g19810 antibody results conflict with other experimental evidence?

When At3g19810 antibody results contradict other experimental data, implement a systematic troubleshooting approach:

• Reassess antibody specificity: Perform comprehensive validation experiments including western blots on wild-type versus knockout tissues, peptide competition assays, and testing on recombinant protein

• Evaluate technical variables: Systematically analyze fixation methods, antigen retrieval conditions, blocking reagents, and antibody concentrations that might affect epitope accessibility

• Consider post-translational modifications: Investigate whether phosphorylation, glycosylation, ubiquitination, or other modifications might mask or alter the epitope recognized by the antibody

• Examine developmental or environmental conditions: Test whether protein expression/detection varies with plant developmental stage, tissue type, or environmental conditions

• Apply orthogonal approaches: Use independent methods like targeted proteomics, RNA expression analysis, or alternative antibodies recognizing different epitopes

• Consider protein complex formation: Determine if protein-protein interactions might mask the epitope

How can computational approaches enhance At3g19810 antibody design and characterization?

Computational approaches can significantly enhance At3g19810 antibody design and characterization through several advanced methods:

• Epitope prediction: Utilize algorithms that analyze protein sequence and structure to predict highly antigenic regions specific to At3g19810, avoiding sequences shared with related DUF177 family members

• Structural modeling: Apply homology modeling and molecular dynamics simulations to predict protein structure and epitope accessibility in native conditions

• Cross-reactivity assessment: Use sequence alignment tools to identify regions unique to At3g19810 versus other Arabidopsis proteins, minimizing potential cross-reactivity

• Antibody design optimization: Implement tools like RosettaAntibodyDesign (RAbD) or multistate design using recon to enhance antibody binding specificity and affinity

• Manufacturability prediction: Integrate tools that predict expression levels and stability to ensure designed antibodies can be reliably produced

These in silico approaches can be integrated into a comprehensive workflow that begins with computational design, proceeds through experimental validation, and iterates based on performance data. Researchers can leverage these tools to predict potential conformational changes in At3g19810 under different experimental conditions that might affect antibody recognition. The increasing relevance of computational approaches is demonstrated by their successful application in rapid antibody development during the SARS-CoV-2 pandemic .

What documentation standards should researchers maintain when using At3g19810 antibody in publications?

When using At3g19810 antibody in publications, researchers should maintain comprehensive documentation standards that include:

• Complete antibody identification: Catalog number, lot number, manufacturer, and RRID (Research Resource Identifier) to enable precise antibody tracking across studies

• Validation evidence: Explicit description of validation experiments performed (western blots, knockout controls, etc.) with representative images included in supplementary materials

• Detailed methodology: Complete protocols including buffer compositions, incubation times/temperatures, antibody dilutions, and antigen retrieval methods

• Control descriptions: Clear documentation of all controls used (positive, negative, genetic, technical) with representative images

• Quantification methods: Detailed explanation of image acquisition parameters, quantification approaches, and statistical analyses

• Limitations disclosure: Honest reporting of any limitations observed with the antibody, such as lot-to-lot variability or context-dependent performance

This level of documentation directly addresses the "antibody characterization crisis" where inadequate antibody characterization has led to irreproducible results and significant research waste . Proper documentation ensures that research using At3g19810 antibody meets current reproducibility standards and allows others to build upon published findings. Consider including raw data in public repositories when possible to further enhance transparency.

How does lot-to-lot variability affect At3g19810 antibody experiments, and how can researchers mitigate this challenge?

Lot-to-lot variability can significantly impact At3g19810 antibody experiments through changes in specificity, sensitivity, and background. Researchers can mitigate these challenges by:

• Purchasing sufficient quantities: Secure enough antibody from a single lot for entire project completion when possible

• Lot-specific validation: Re-validate each new antibody lot using western blots against known positive controls and knockout/knockdown negative controls

• Comparative testing period: When transitioning between lots, run parallel experiments with both old and new lots to establish correlation factors

• Reference standard maintenance: Keep aliquots of well-characterized samples as reference standards for validating new lots

• Detailed record-keeping: Maintain comprehensive records associating specific lots with experimental results

• Standardized protocols: Develop robust, standardized protocols that include internal controls to normalize for antibody performance variations

• Alternative options exploration: Consider generating monoclonal antibodies for critical applications requiring long-term consistency

The antibody market has expanded from approximately 10,000 commercially available antibodies 15 years ago to more than six million today , increasing the challenges of quality control and consistency. By implementing these mitigating strategies, researchers can reduce the impact of lot variability on experimental outcomes and enhance reproducibility across studies.

What are the best protocols for using At3g19810 antibody in chromatin immunoprecipitation (ChIP) experiments?

For optimized chromatin immunoprecipitation (ChIP) using At3g19810 antibody, implement this specialized protocol:

• Crosslinking optimization: Test multiple formaldehyde concentrations (0.5-3%) and incubation times (5-20 minutes) to determine optimal conditions for At3g19810 protein-DNA crosslinking

• Chromatin preparation:

  • Harvest 3-5 g of Arabidopsis tissue and crosslink in buffer containing formaldehyde

  • Quench with 0.125 M glycine for 5 minutes

  • Wash thoroughly with ice-cold PBS

  • Extract nuclei using Honda buffer (0.44 M sucrose, 1.25% Ficoll, 2.5% Dextran T40, 20 mM HEPES pH 7.4, 10 mM MgCl₂, 0.5% Triton X-100, 5 mM DTT, protease inhibitors)

  • Resuspend in nuclear lysis buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS, protease inhibitors)

• Sonication calibration: Optimize sonication conditions to generate DNA fragments of 200-500 bp (typically 10-15 cycles of 30 seconds on/30 seconds off using a Bioruptor sonicator)

• Immunoprecipitation:

  • Dilute chromatin 1:10 in ChIP dilution buffer (16.7 mM Tris-HCl pH 8.0, 1.2 mM EDTA, 167 mM NaCl, 1.1% Triton X-100, 0.01% SDS)

  • Pre-clear with Protein A/G beads for 1 hour at 4°C

  • Add 5-10 μg of At3g19810 antibody and incubate overnight at 4°C with rotation

  • Add fresh Protein A/G beads and incubate for 3 hours

  • Perform sequential washes with low salt, high salt, LiCl, and TE buffers

• DNA recovery and analysis:

  • Elute DNA-protein complexes with elution buffer (1% SDS, 0.1 M NaHCO₃)

  • Reverse crosslinks (65°C overnight with 0.2 M NaCl)

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Analyze by qPCR or next-generation sequencing

Include appropriate controls: input DNA (pre-immunoprecipitation), IgG control (non-specific antibody), and positive control regions (if known). For Arabidopsis, the high content of polyphenolic compounds and cell wall materials requires additional purification steps to reduce background and improve signal-to-noise ratio.

How can researchers use At3g19810 antibody to study protein localization and trafficking in Arabidopsis cells?

To study At3g19810 protein localization and trafficking in Arabidopsis cells, implement these specialized approaches:

• Immunofluorescence microscopy in fixed tissues:

  • Fix Arabidopsis tissues in 4% paraformaldehyde

  • Perform enzymatic or mechanical cell wall digestion for improved antibody penetration

  • Permeabilize with 0.2-0.5% Triton X-100

  • Block with 5% normal goat serum, 1% BSA, 0.2% Triton X-100

  • Incubate with At3g19810 antibody (1:25 to 1:250 dilution)

  • Apply fluorophore-conjugated secondary antibody

  • Counterstain with organelle markers (e.g., DAPI for nucleus, MitoTracker for mitochondria)

  • Image using confocal microscopy with appropriate controls

• Co-localization analysis with organelle markers:

  • Calculate Pearson's correlation coefficient between At3g19810 signal and various organelle markers

  • Perform object-based colocalization analysis to quantify association

  • Use line scan analysis across cellular compartments to determine relative localization

• Live-cell imaging with immunolabeling:

  • Generate GFP-tagged At3g19810 constructs for transient expression

  • Validate fusion protein functionality and compare localization with antibody staining

  • Perform time-lapse imaging to track protein movement

  • Quantify trafficking dynamics using photobleaching or photoactivation techniques

• Subcellular fractionation combined with immunoblotting:

  • Fractionate Arabidopsis tissues into distinct subcellular compartments

  • Perform western blotting with At3g19810 antibody on each fraction

  • Include compartment-specific marker proteins to validate fractionation purity

When optimizing immunofluorescence protocols for plant cells, consider the challenges of cell wall permeability, fixation effects on antigen accessibility, and plant autofluorescence. The application of mild cell wall digestion (using enzymes like cellulase and macerozyme) followed by careful permeabilization often improves antibody penetration while preserving cellular architecture.

How might emerging antibody technologies enhance At3g19810 research in the coming years?

Emerging antibody technologies poised to revolutionize At3g19810 research include:

• Recombinant antibody development: Moving beyond hybridoma-based methods to recombinant approaches allows for precise engineering of antibody properties, including enhanced specificity for At3g19810 and reduced cross-reactivity with related DUF177 family proteins

• Single-domain antibodies (nanobodies): Developing camelid-derived nanobodies against At3g19810 could provide superior access to cryptic epitopes and enhanced penetration in plant tissues due to their small size (~15 kDa compared to ~150 kDa for conventional antibodies)

• Proximity labeling antibody conjugates: Conjugating At3g19810 antibodies with enzymes like BioID or APEX2 enables identification of transient protein interactions and proximal proteins in native cellular contexts

• Bispecific antibodies: Creating antibodies that simultaneously recognize At3g19810 and another protein of interest could help map protein complex formation in plant cells

• Antibody fragments with enhanced tissue penetration: Developing Fab and scFv fragments against At3g19810 could improve access to dense plant tissues and organelles

• Computationally designed antibodies: Utilizing advanced in silico approaches like RosettaAntibodyDesign (RAbD) to create antibodies with optimized binding properties specific to At3g19810

These technologies address current limitations in antibody-based plant research, potentially resolving issues with the estimated 50% of commercial antibodies that fail to meet basic characterization standards . As these technologies mature, they will enable more precise studies of At3g19810's function, localization, and interactions in Arabidopsis thaliana.

What interdisciplinary approaches might provide new insights into At3g19810 function using antibody-based techniques?

Innovative interdisciplinary approaches can provide breakthrough insights into At3g19810 function through these integrated strategies:

• Systems biology integration: Combine At3g19810 antibody-based proteomics with transcriptomics, metabolomics, and phenomics to place the protein within comprehensive regulatory networks

• Structural biology coupling: Pair antibody-based protein purification with cryo-electron microscopy or X-ray crystallography to resolve At3g19810's three-dimensional structure and functional domains

• Synthetic biology applications: Use antibody-based detection to monitor engineered variants of At3g19810 with modified domains or regulatory elements to dissect functional regions

• Plant-microbe interaction studies: Apply At3g19810 antibodies in the context of plant pathology to determine if the protein plays roles in immune responses or microbial interactions

• Developmental biology integration: Combine antibody-based tissue imaging with live cell reporters to track At3g19810 expression and localization throughout plant development

• Environmental response mapping: Use high-throughput antibody-based assays to measure At3g19810 expression across diverse environmental conditions, creating response maps

• Comparative genomics with proteomics: Analyze At3g19810 homologs across plant species using species-specific or cross-reactive antibodies to understand evolutionary conservation of function

These interdisciplinary approaches address the challenge that approximately 50% of commercial antibodies fail to meet basic standards for characterization , by placing antibody-based research within broader experimental contexts that provide multiple lines of evidence. The integration of computational approaches, particularly those developed for antibody design during recent public health challenges , further enhances these interdisciplinary strategies.